Radiopharm Theranostics LimitedASX: RAD

RAD Approval for Phase 1 Therapeutic Trial of RAD 402

Nov 18, 2025 at 2:52 AM UTC · Issued by Radiopharm Theranostics Limited

Radiopharm Theranostics Ltd has released a press release.

View Attachment